Description
What is Sildenafil?
Sildenafil is a small-molecule phosphodiesterase type 5 (PDE5) inhibitor and a foundational reference compound in cyclic-nucleotide pharmacology. A pyrazolopyrimidinone, it acts as a potent, selective competitive inhibitor at the catalytic site of PDE5, the enzyme that hydrolyzes cyclic GMP. Supplied as oral tablets for laboratory reference use in studying nitric-oxide-cGMP signaling and vascular smooth-muscle biology.
How Sildenafil works (research context)
Within the nitric-oxide-cGMP axis, nitric oxide activates soluble guanylate cyclase to generate cGMP, which relaxes smooth muscle; PDE5 normally degrades cGMP to terminate the signal. Sildenafil occupies the PDE5 catalytic pocket, competitively blocking cGMP hydrolysis so the second messenger accumulates and signaling persists, amplifying cGMP-dependent protein kinase G activity in research models.
Research applications
- Reference PDE5 inhibitor for in-vitro cyclic-nucleotide assays
- Pharmacological tool in vascular and pulmonary smooth-muscle models
- Selectivity profiling across the phosphodiesterase isoenzyme family
- Structure-activity reference in PDE-inhibitor medicinal chemistry
Key facts
- Selective competitive inhibitor at the PDE5 catalytic site
- Pyrazolopyrimidinone small molecule; commonly the citrate salt
- Acts within the NO-soluble guanylate cyclase-cGMP-PKG cascade
- Relatively short-acting profile versus long-acting PDE5 inhibitors
Product specifications
- Class: Phosphodiesterase type 5 (PDE5) inhibitor, small molecule
- Also known as: Sildenafil citrate; PDE5 inhibitor
- Form: Oral tablets
- Verification: Identity and quality checked per batch
- Documentation: Certificate of analysis per batch
- Storage: Store tablets at controlled room temperature in a dry, light-protected container.
For laboratory research use only. Not for human or veterinary use, consumption, diagnostic, or therapeutic purposes.








D. Mwangi (verified owner) –
Reference material checks out and the assay matched, but a back-ordered restock delayed my last order by two weeks with little communication. Quality was fine once it finally arrived.
Hannah Vogel –
Tablets uniform, COA included, discreet packaging. Exactly what we needed for smooth-muscle assays.
Dr. Paolo Greco (verified owner) –
Selectivity profiling across the PDE family used this as the benchmark — behaved exactly as characterized. Solid lab reference.
Dr. Conrad Bishop (verified owner) –
Sildenafil reference tablets — HPLC assay matched the stated 100mg and the COA was thorough. Clean PDE5 inhibition in our cGMP assay.
Yelena Markova (verified owner) –
Consistent tablet content and clear potency documentation. Reliable PDE5 reference for cyclic-nucleotide work.